I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Schleif, W A
120
results:
Search for persons
X
Format
Online (118)
Print (2)
Mediatypes
Books (2)
Articles (Online) (36)
OpenAccess-fulltext (82)
Languages
german (2)
english (115)
Sorted by: Relevance
Sorted by: Year
?
1
Caffeine protects Alzheimer's mice against cognitive impair..:
Arendash, G.W.
;
Schleif, W.
;
Rezai-Zadeh, K.
...
Neuroscience. 142 (2006) 4 - p. 941-952 , 2006
Link:
https://doi.org/10.1016/..
?
2
Combination Therapy with Zidovudine Prevents Selection of H..:
Staszewski, S.
;
Massari, F. E.
;
Kober, A.
...
The Journal of Infectious Diseases. 171 (1995) 5 - p. 1159-1165 , 1995
Link:
https://www.jstor.org/st..
?
3
CLINICAL DEVELOPMENT OF HIV-1 RESISTANCE TO THE VIRAL PROTE..:
Emini, E A
;
Deutsch, P
;
Schleif, W A
.
AIDS. 8 (1994) Supplement 4 - p. S10 , 1994
Link:
https://doi.org/10.1097/..
?
4
L-735,524: An Orally Bioavailable Human Immunodeficiency Vi..:
Vacca, J. P.
;
Dorsey, B. D.
;
Schleif, W. A.
...
Proceedings of the National Academy of Sciences of the United States of America. 91 (1994) 9 - p. 4096-4100 , 1994
Link:
https://www.jstor.org/st..
?
5
L-735,524: an orally bioavailable human immunodeficiency vi..:
Vacca, J P
;
Dorsey, B D
;
Schleif, W A
...
Proceedings of the National Academy of Sciences. 91 (1994) 9 - p. 4096-4100 , 1994
Link:
https://doi.org/10.1073/..
?
6
Prevention of HIV-1 infection in chimpanzees by gpl20 V3 do..:
Emini, E. A.
;
Schleif, W. A.
;
Nunberg, J. H.
...
Nature. 355 (1992) 6362 - p. 728-730 , 1992
Link:
https://doi.org/10.1038/..
?
7
Pyridinone derivatives: specific human immunodeficiency vir..:
Goldman, M E
;
Nunberg, J H
;
O'Brien, J A
...
Proceedings of the National Academy of Sciences. 88 (1991) 15 - p. 6863-6867 , 1991
Link:
https://doi.org/10.1073/..
?
8
Active human immunodeficiency virus protease is required fo..:
Kohl, N E
;
Emini, E A
;
Schleif, W A
...
Proceedings of the National Academy of Sciences. 85 (1988) 13 - p. 4686-4690 , 1988
Link:
https://doi.org/10.1073/..
?
9
Genetic correlates of in vivo viral resistance to indinavir..:
Condra, J H
;
Holder, D J
;
Schleif, W A
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC190914. , 1996
Link:
http://www.ncbi.nlm.nih...
?
10
The consequence of passive administration of an anti-human ..:
Conley, A J
;
Kessler JA, I I
;
Boots, L J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC190718. , 1996
Link:
http://www.ncbi.nlm.nih...
?
11
L-735,524: an orally bioavailable human immunodeficiency vi..:
Vacca, J P
;
Dorsey, B D
;
Schleif, W A
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC43730. , 1994
Link:
http://www.ncbi.nlm.nih...
?
12
Susceptibilities of human immunodeficiency virus type 1 enz..:
Byrnes, V W
;
Emini, E A
;
Schleif, W A
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC188219. , 1994
Link:
http://www.ncbi.nlm.nih...
?
13
A nonnucleoside reverse transcriptase inhibitor active on h..:
Goldman, M E
;
O'Brien, J A
;
Ruffing, T L
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC187857. , 1993
Link:
http://www.ncbi.nlm.nih...
?
14
Comprehensive mutant enzyme and viral variant assessment of..:
Byrnes, V W
;
Sardana, V V
;
Schleif, W A
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC188022. , 1993
Link:
http://www.ncbi.nlm.nih...
?
15
Requirement of active human immunodeficiency virus type 1 i..:
LaFemina, R L
;
Schneider, C L
;
Robbins, H L
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC240448. , 1992
Link:
http://www.ncbi.nlm.nih...
1-15
Related subjects
Ralph Ellison